title: Use of continuous subcutaneous insulin infusion in cystic fibrosis patients with cystic fibrosis-related diabetes awaiting transplantation.
authors.forename: Maria Francesca
authors.initials: MF
authors.lastname: Reali
authors.forename: Filippo
authors.initials: F
authors.lastname: Festini
authors.forename: Anna Silvia
authors.initials: AS
authors.lastname: Neri
authors.forename: Giovanni
authors.initials: G
authors.lastname: Taccetti
authors.forename: Teresa
authors.initials: T
authors.lastname: Repetto
authors.forename: Francesco
authors.initials: F
authors.lastname: Chiarelli
authors.forename: Sonia
authors.initials: S
authors.lastname: Toni
mesh_terms: D000328:Adult; D003550:Cystic Fibrosis / Q000150:complications* / Q000601:surgery; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage* / Q000627:therapeutic use; D007332:Insulin Infusion Systems; D016031:Liver Transplantation; D016040:Lung Transplantation; D014850:Waiting Lists
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin